TidalSense, a Cambridge-based healthtech startup, raised 19 million USD in a funding round. The round included new investor Cross-Border Impact Ventures and returning investors BGF, Airstream Capital and Foresight Group. The company said it will use the funding to accelerate rollout of its COPD diagnostic test across the NHS, expand in Europe, and pursue entry into the US market. The company was founded in 2013 and says it has raised 40 million USD in total, including 11 million USD in grant funding.
About TidalSense
A UK healthtech startup building AI-powered respiratory diagnostic technology, starting with COPD detection through its N-Tidal Diagnose test.
Cambridge, United Kingdom
Read Company Profile
Source: https://tech.eu/2026/07/24/uk-health-startup-using-ai-to-cut-lung-disease-test-time-clinches-19m/
Frequently Asked Questions
What type of funding round did TidalSense raise?
TidalSense raised a unspecified round.
How much did TidalSense raise in its unspecified?
TidalSense raised $19,000,000 USD in its unspecified.
When did TidalSense raise its unspecified?
TidalSense raised its unspecified on 2026-07-24.
Who invested in TidalSense's unspecified?
The investors in TidalSense's unspecified are: Cross-Border Impact Ventures, BGF, Airstream Capital, Foresight Group.
What type of investment was TidalSense's unspecified?
TidalSense's unspecified was a equity investment.
How will TidalSense use the funds from its unspecified?
TidalSense plans to use the funds for: speed up rollout across the NHS, expand across Europe, enter the US market.